Risedronic acid vs ibandronic acid: a cost-effective analysis

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.539, 2007-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alendronic acid/ibandronic acid/risedronic acid: Osteonecrosis of the jaw: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1176, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Alendronic acid/ibandronic acid/risedronic acid: Osteonecrosis of the jaw treated with teriparatide in elderly patients: 6 case reports

Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Alendronic acid appears to be more effective than risedronic acid for preventing fractures in patients with rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Risedronic acid: Hypocalcaemia: case report

Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

Alendronic acid superior to risedronic acid in osteoporosis

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite